Dengue viruses and promising envelope protein domain III-based vaccines
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dengue viruses and promising envelope protein domain III-based vaccines
Authors
Keywords
Dengue virus, Envelope protein, Chimeric vaccine, Disease, Immunogenicity
Journal
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
Volume 102, Issue 7, Pages 2977-2996
Publisher
Springer Nature
Online
2018-02-22
DOI
10.1007/s00253-018-8822-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys
- (2017) Georg F. Bischof et al. JOURNAL OF VIROLOGY
- Evaluation in Mice of the Immunogenicity of a Tetravalent Subunit Vaccine Candidate Against Dengue Virus Using Mucosal and Parenteral Immunization Routes
- (2017) Laura Lazo Vázquez et al. VIRAL IMMUNOLOGY
- Effective Protection Induced by a Monovalent DNA Vaccine against Dengue Virus (DV) Serotype 1 and a Bivalent DNA Vaccine against DV1 and DV2 in Mice
- (2017) Xiaoyan Zheng et al. Frontiers in Cellular and Infection Microbiology
- A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus
- (2017) Hamed Haddad Kashani et al. Frontiers in Cellular and Infection Microbiology
- Multi-walled carbon nanotubes functionalized with recombinant Dengue virus 3 envelope proteins induce significant and specific immune responses in mice
- (2017) Alice F. Versiani et al. JOURNAL OF NANOBIOTECHNOLOGY
- Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies
- (2016) Niyati Khetarpal et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies
- (2016) Ankur Poddar et al. BMC BIOTECHNOLOGY
- Induction of multiple cytotoxic T lymphocyte responses in mice by a multiepitope DNA vaccine against dengue virus serotype 1
- (2016) Xin Yu Chen et al. MICROBIOLOGY AND IMMUNOLOGY
- Oral immunisation of mice with transgenic rice calli expressing cholera toxin B subunit fused to consensus dengue cEDIII antigen induces antibodies to all four dengue serotypes
- (2016) Mi-Young Kim et al. PLANT MOLECULAR BIOLOGY
- Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice
- (2016) Chen-Yi Chiang et al. VACCINE
- Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates
- (2016) Sean P. McBurney et al. VACCINE
- Status of vaccine research and development of vaccines for dengue
- (2016) Kirsten S. Vannice et al. VACCINE
- Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
- (2016) Chen-Yi Chiang et al. Scientific Reports
- Purification of Antibacterial CHAPK Protein Using a Self-Cleaving Fusion Tag and Its Activity Against Methicillin-Resistant Staphylococcus aureus
- (2016) Elahe Seyed Hosseini et al. Probiotics and Antimicrobial Proteins
- A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys
- (2015) Edith Suzarte et al. INTERNATIONAL IMMUNOLOGY
- Cooperation between CD4+ T Cells and Humoral Immunity Is Critical for Protection against Dengue Using a DNA Vaccine Based on the NS1 Antigen
- (2015) Antônio J. S. Gonçalves et al. PLoS Neglected Tropical Diseases
- A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice
- (2014) Alienys Izquierdo et al. ARCHIVES OF VIROLOGY
- Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus
- (2014) Edith Suzarte et al. ARCHIVES OF VIROLOGY
- The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2
- (2014) Lázaro Gil et al. IMMUNOLOGY AND CELL BIOLOGY
- A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates
- (2013) Hsin-Wei Chen et al. ARCHIVES OF VIROLOGY
- Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III
- (2013) Chen-Yi Chiang et al. MICROBES AND INFECTION
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
- (2013) Shailendra Mani et al. PLoS One
- Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae
- (2013) Ngoc-Luong Nguyen et al. PROTEIN EXPRESSION AND PURIFICATION
- Targeting of envelope domain III protein of DENV type 2 to DEC-205 receptor elicits neutralizing antibodies in mice
- (2013) Nancy Coconi-Linares et al. VACCINE
- Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year
- (2013) Magelda Montoya et al. PLoS Neglected Tropical Diseases
- Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus
- (2012) Ernesto Marcos et al. ARCHIVES OF VIROLOGY
- Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli
- (2012) Jie Yang et al. CANADIAN JOURNAL OF MICROBIOLOGY
- M Cell-Targeting Ligand and Consensus Dengue Virus Envelope Protein Domain III Fusion Protein Production in Transgenic Rice Calli
- (2012) Tae-Geum Kim et al. MOLECULAR BIOTECHNOLOGY
- Expression of a consensus dengue virus envelope protein domain III in transgenic callus of rice
- (2012) Mi-Young Kim et al. PLANT CELL TISSUE AND ORGAN CULTURE
- Expression, Purification and Evaluation of Diagnostic Potential and Immunogenicity of Dengue Virus Type 3 Domain III Protein
- (2012) Pradeep B.J. Reddy et al. PROTEIN AND PEPTIDE LETTERS
- Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo
- (2012) Katherine L. Williams et al. VIROLOGY
- Dengue-1 Envelope Protein Domain III along with PELC and CpG Oligodeoxynucleotides Synergistically Enhances Immune Responses
- (2012) Chen-Yi Chiang et al. PLoS Neglected Tropical Diseases
- Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus
- (2012) Oliver J. Brady et al. PLoS Neglected Tropical Diseases
- Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
- (2012) Upasana Arora et al. JOURNAL OF NANOBIOTECHNOLOGY
- Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli
- (2011) Nagesh K. Tripathi et al. Biotechnology Journal
- The Chimeric Protein Domain III-Capsid of Dengue Virus Serotype 2 (DEN-2) Successfully Boosts Neutralizing Antibodies Generated in Monkeys upon Infection with DEN-2
- (2011) Iris Valdés et al. Clinical and Vaccine Immunology
- A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness
- (2011) V.J. Gunther et al. VACCINE
- Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus
- (2010) Laura Lazo et al. ARCHIVES OF VIROLOGY
- Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization
- (2010) Juliana Helena Chávez et al. BIOLOGICALS
- Review of dengue virus and the development of a vaccine
- (2010) Sarah Murrell et al. BIOTECHNOLOGY ADVANCES
- Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease
- (2010) Raphaël M. Zellweger et al. Cell Host & Microbe
- Domain III of the envelope protein as a dengue vaccine target
- (2010) Maria G Guzman et al. Expert Review of Vaccines
- Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris
- (2010) Gaurav Batra et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- Immunodominance and Functional Activities of Antibody Responses to Inactivated West Nile Virus and Recombinant Subunit Vaccines in Mice
- (2010) J. Zlatkovic et al. JOURNAL OF VIROLOGY
- A recombinant lipoprotein containing an unsaturated fatty acid activates NF-κB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide
- (2010) Chih-Hsiang Leng et al. MOLECULAR IMMUNOLOGY
- A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice
- (2010) Olivia K.T. Block et al. VACCINE
- Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses
- (2010) Samantha Brandler et al. VACCINE
- Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys
- (2010) David E. Clements et al. VACCINE
- Construction and immunogenicity of DNA vaccines encoding fusion protein of murine complement C3d-p28 and GP5 gene of porcine reproductive and respiratory syndrome virus
- (2010) Deqing Zhang et al. VACCINE
- Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection
- (2010) Qun Zheng et al. VACCINE
- A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection
- (2010) Danielle Malta Lima et al. VACCINE
- A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice
- (2010) Gunther Spohn et al. Virology Journal
- Immunogenicity of novel Dengue virus epitopes identified by bioinformatic analysis
- (2010) Gilma Sánchez-Burgos et al. VIRUS RESEARCH
- Serotype-Specific Differences in the Risk of Dengue Hemorrhagic Fever: An Analysis of Data Collected in Bangkok, Thailand from 1994 to 2006
- (2010) Jessica R. Fried et al. PLoS Neglected Tropical Diseases
- Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
- (2010) Scott J. Balsitis et al. PLoS Pathogens
- Dengue virus-induced hemorrhage in a nonhuman primate model
- (2009) N. Onlamoon et al. BLOOD
- On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes
- (2009) R. Rajamanonmani et al. JOURNAL OF GENERAL VIROLOGY
- Crystal Structure of Dengue Virus Type 1 Envelope Protein in the Postfusion Conformation and Its Implications for Membrane Fusion
- (2009) V. Nayak et al. JOURNAL OF VIROLOGY
- Modulation of intein activity by its neighboring extein substrates
- (2009) G. Amitai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity
- (2009) Saima Khanam et al. VACCINE
- Development of a novel DNA SynCon™ tetravalent dengue vaccine that elicits immune responses against four serotypes
- (2009) Mathura P. Ramanathan et al. VACCINE
- A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design
- (2009) Hsin-Wei Chen et al. VACCINE
- Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
- (2009) W.M.P.B. Wahala et al. VIROLOGY
- Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates
- (2008) L BERNARDO et al. ANTIVIRAL RESEARCH
- Dengue-4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in mice
- (2008) Laura Lazo et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Production and characterization of recombinant dengue virus type 4 envelope domain III protein
- (2008) N TRIPATHI et al. JOURNAL OF BIOTECHNOLOGY
- A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus
- (2008) K. Raviprakash et al. JOURNAL OF VIROLOGY
- Construction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2
- (2008) R. Suzuki et al. JOURNAL OF VIROLOGY
- Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus
- (2008) G. D. Gromowski et al. JOURNAL OF VIROLOGY
- Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model
- (2008) Chiou-Feng Lin et al. LABORATORY INVESTIGATION
- A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity
- (2008) Chih-Hsiang Leng et al. MICROBES AND INFECTION
- Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
- (2008) Bruno Guy et al. VACCINE
- Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4
- (2008) Joseph E. Blaney et al. VACCINE
- Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen
- (2008) Adrian C.N. Sim et al. VACCINE
- Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice
- (2008) J. Pradeep Babu et al. VACCINE
- “Guidelines for the clinical evaluation of dengue vaccines in endemic areas”: Summary of a World Health Organization Technical Consultation
- (2008) Robert Edelman et al. VACCINE
- Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidis
- (2008) Iris Valdés et al. VACCINE
- Towards a dengue vaccine: Progress to date and remaining challenges
- (2007) Bruno Guy et al. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started